book review: fundamentals of medicinal chemistry. by gareth thomas

1
Fundamentals of Medicinal Chemistry By Gareth Thomas. Wiley, Chichester 2003. 302 pp., soft cover $ 30.00.–ISBN 0-470-84307-1 A number of aspects of synthetic, bioor- ganic and physical organic chemistry can be illustrated with relevant examples from the realm of medicinal chemistry. Furthermore, the pharmaceutical indus- try is a major employer of chemists and biochemists. Consequently, a series of medicinal chemistry lectures often forms a component of chemistry programmes. This book is aimed at second and third year undergraduates taking such a course against a background of chemis- try or biochemistry. Although this book may invite comparison with the author';s earlier Medicinal Chemistry , it is aimed at a different market. The book assumes only a level of chemical knowledge that would be obtained from the first year of a chemistry course. It makes very few de- mands on biological knowledge and it includes in the appendices some essen- tial details of cellular structure and func- tion. The opening two chapters of the book set the subject in the context of bio- organic chemistry and aim to provide an overview of medicinal chemistry in order to develop a framework for the succeed- ing chapters. There is a discussion of the classification of drugs, their absorption, distribution, metabolism and excretion. The next four chapters are concerned with the factors that are involved in the design of a drug, the development of structure±activity relationships and newer combinatorial methods of synthe- sis. The remaining chapters exemplify drug action at particular targets, phar- macokinetics and drug metabolism, with the final chapters being concerned with the synthesis and production of a drug. Each chapter is accompanied by ques- tions covering the major points. The an- swers are given at the end of the book, where there is also guidance for further reading. The book is nicely presented, and the chapters contain clear headings for the various sections. Keywords are set in bold. However, there are a few errors in the formulae. It is a pity that the book did not discuss more of the aetiology of a disease and then the various strategies that have been developed to combat it. Nevertheless, this is an interesting and useful book that fulfils its purpose in providing a foundation of medicinal chemistry. Jim Hanson University of Sussex (UK) DOI: 10.1002/cbic.200300160 Methods and Principles in Medicinal Chemistry Vol. 21: Molecular Biology in Medicinal Chemistry Edited by Theodor Dingermann, Dieter Steinhilber and Gerd Folkers. Wiley-VCH, Weinheim 2004. 413 pp., hard cover E 149.00.–ISBN 3-527-30431-2 The elucidation of the human genome and the huge number of targets is a true challenge for me- dicinal chemistry. The criteria for target selection and the drugabili- ty of the targets are now even more im- portant. What does the target do within cells and how do you monitor it in a complex system? Where to start? What to synthesize and how? All this in a single book titled Molecular Biology in Medicinal Chemistry ? The 14 chapters by just as many au- thors or teams are grouped into four sections : molecular targets; synthesis; analysis; and kinetics, metabolism, and toxicology. This order reflects the re- search process in pharmaceutical indus- try. The first chapter lists cellular assays in drug discovery and addresses the ex- perienced reader. This is a particularly crucial task for the authors. They rush through a general review and slow down a little to focus on assay tech- nologies; such as FRET, BRET, FLIPR, AlphaScreen¦, reporter genes, and enzyme fragment complementation. The descriptions are very brief ( 1 = 2 ±1 page per assay), and detailed information is given only occasionally for GPCRs, ion channels, and reporter-gene assays for transmembrane receptors. Some assays are summarized in nice flow charts, but the physicochemical background of the assays remains in a black box for now (most of them will be discussed in fol- lowing chapters). The opportunity to dis- cuss false positives and negatives was missed. Only reporter-gene assays are treated at the necessary depth. The second chapter: gene knockout models, deals with the manipulation of embryon- ic stems cells to generate knockout mouse models. The descriptions and fig- ures are very instructive; the drug resist- ance/sensitivity markers Neomycine/Gan- ciclovir are well explained, so is the gen- eration of blastocysts and the breeding pattern. The ten pages for the novice are followed by twelve pages on conditional knockouts using LoxP/CRE, the tetracy- cline-responsive system, transgenic mice, Drosophila and finally the morpholino oligos in Zebra fish embryos. Two con- cise chapters follow on GPCRs: reporter- gene assays and the ligand hunt for orphan GPCRs. FLIPR and Ca 2 + -mediated signaling are pulled out of the black box now. The rather small Part II is devoted Fundamentally Medicinal ChemBioChem 2004, 5, 1153 ± 1156 www.chembiochem.org ¹ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 1153

Upload: jim-hanson

Post on 06-Jun-2016

217 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Book Review: Fundamentals of Medicinal Chemistry. By Gareth Thomas

Fundamentals of MedicinalChemistryBy Gareth Thomas.

Wiley, Chichester 2003. 302 pp. , soft cover$ 30.00.–ISBN 0-470-84307-1

A number of aspects of synthetic, bioor-ganic and physical organic chemistry canbe illustrated with relevant examplesfrom the realm of medicinal chemistry.Furthermore, the pharmaceutical indus-try is a major employer of chemists andbiochemists. Consequently, a series ofmedicinal chemistry lectures often formsa component of chemistry programmes.

This book is aimed at second andthird year undergraduates taking such acourse against a background of chemis-try or biochemistry. Although this bookmay invite comparison with the author';searlier Medicinal Chemistry, it is aimed ata different market. The book assumesonly a level of chemical knowledge thatwould be obtained from the first year ofa chemistry course. It makes very few de-mands on biological knowledge and itincludes in the appendices some essen-tial details of cellular structure and func-tion.

The opening two chapters of the bookset the subject in the context of bio-organic chemistry and aim to provide anoverview of medicinal chemistry in orderto develop a framework for the succeed-ing chapters. There is a discussion of theclassification of drugs, their absorption,distribution, metabolism and excretion.The next four chapters are concernedwith the factors that are involved in thedesign of a drug, the developmentof structure±activity relationships andnewer combinatorial methods of synthe-sis. The remaining chapters exemplifydrug action at particular targets, phar-macokinetics and drug metabolism, withthe final chapters being concerned withthe synthesis and production of a drug.Each chapter is accompanied by ques-

tions covering the major points. The an-swers are given at the end of the book,where there is also guidance for furtherreading.

The book is nicely presented, and thechapters contain clear headings for thevarious sections. Keywords are set inbold. However, there are a few errors inthe formulae. It is a pity that the bookdid not discuss more of the aetiology ofa disease and then the various strategiesthat have been developed to combat it.Nevertheless, this is an interesting anduseful book that fulfils its purpose inproviding a foundation of medicinalchemistry.

Jim HansonUniversity of Sussex (UK)DOI: 10.1002/cbic.200300160

Methods and Principles inMedicinal Chemistry Vol. 21:Molecular Biology inMedicinal ChemistryEdited by Theodor Dingermann,Dieter Steinhilber and Gerd Folkers.

Wiley-VCH, Weinheim 2004. 413 pp. , hardcover E 149.00.–ISBN 3-527-30431-2

The elucidationof the humangenome and thehuge number oftargets is a truechallenge for me-dicinal chemistry.The criteria fortarget selectionand the drugabili-ty of the targets are now even more im-portant. What does the target do withincells and how do you monitor it in acomplex system? Where to start? Whatto synthesize and how? All this in a

single book titled Molecular Biology inMedicinal Chemistry?

The 14 chapters by just as many au-thors or teams are grouped into foursections: molecular targets; synthesis ;analysis; and kinetics, metabolism, andtoxicology. This order reflects the re-search process in pharmaceutical indus-try. The first chapter lists cellular assaysin drug discovery and addresses the ex-perienced reader. This is a particularlycrucial task for the authors. They rushthrough a general review and slowdown a little to focus on assay tech-nologies; such as FRET, BRET, FLIPR,AlphaScreen¦, reporter genes, andenzyme fragment complementation. Thedescriptions are very brief (1=2±1 pageper assay), and detailed information isgiven only occasionally for GPCRs, ionchannels, and reporter-gene assays fortransmembrane receptors. Some assaysare summarized in nice flow charts, butthe physicochemical background of theassays remains in a black box for now(most of them will be discussed in fol-lowing chapters). The opportunity to dis-cuss false positives and negatives wasmissed. Only reporter-gene assays aretreated at the necessary depth. Thesecond chapter : gene knockout models,deals with the manipulation of embryon-ic stems cells to generate knockoutmouse models. The descriptions and fig-ures are very instructive; the drug resist-ance/sensitivity markers Neomycine/Gan-ciclovir are well explained, so is the gen-eration of blastocysts and the breedingpattern. The ten pages for the novice arefollowed by twelve pages on conditionalknockouts using LoxP/CRE, the tetracy-cline-responsive system, transgenic mice,Drosophila and finally the morpholinooligos in Zebra fish embryos. Two con-cise chapters follow on GPCRs: reporter-gene assays and the ligand hunt fororphan GPCRs. FLIPR and Ca2+-mediatedsignaling are pulled out of the black boxnow. The rather small Part II is devoted

Fundamentally Medicinal

ChemBioChem 2004, 5, 1153 ± 1156 www.chembiochem.org ¹ 2004 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 1153